Page last updated: 2024-11-05

trimethobenzamide and Intracranial Arteriosclerosis

trimethobenzamide has been researched along with Intracranial Arteriosclerosis in 1 studies

trimethobenzamide: major descriptor (64-84); on-line search BENZAMIDES (64-84); Index Medicus search TRIMETHOBENZAMIDE (64-84); RN given refers to parent cpd
trimethobenzamide : The amide obtained by formal condensation of 3,4,5-trihydroxybenzoic acid with 4-[2-(N,N-dimethylamino)ethoxy]benzylamine. It is used to prevent nausea and vomitting in humans.

Intracranial Arteriosclerosis: Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
STERN, FH1

Other Studies

1 other study available for trimethobenzamide and Intracranial Arteriosclerosis

ArticleYear
COMPARISON OF THREE AGENTS (TIGACOL, DRAMAMINE AND ANTIVERT) FOR THE CONTROL OF DIZZINESS IN GERIATRIC PATIENTS.
    Journal of the American Geriatrics Society, 1963, Volume: 11

    Topics: Alcohols; Benzamides; Cochlear Nerve; Dimenhydrinate; Dizziness; Geriatrics; Humans; Intracranial Ar

1963